STOCKHOLM: The Nobel Assembly at Karolinska Institutet has awarded the 2026 Nobel Prize in Physiology or Medicine jointly to Karl Deisseroth, Peter Hegemann, and Georg Nagel for the groundbreaking development of optogenetics—a transformative technology that uses light to control the electrical firing of individual brain cells in living organisms.
How does optogenetics use light to control neuronal circuits?
The scientific breakthrough originated with biophysicists Peter Hegemann (Humboldt University of Berlin) and Georg Nagel (University of Würzburg), who discovered channelrhodopsins—specialized light-gated ion channel proteins found naturally in green microalgae. In a historic leap in the mid-2000s, Stanford neuroengineer Dr. Karl Deisseroth introduced these microbial light-sensitive genes into mammalian neurons using viral vectors, successfully directing targeted pulses of laser light via microscopic optical fibers to selectively trigger or suppress action potentials with millisecond precision.
Prior to optogenetics, neuroscientists relied on coarse pharmacological drugs or electrical stimulation that indiscriminately stimulated thousands of neighboring cells. Optogenetics enabled single-cell precision mapping for the first time in medical history.
Why is this discovery transformative for Parkinson's, blindness, and psychiatry?
According to the Nobel citation, optogenetics has provided unprecedented causative understanding of fundamental neurological circuits governing memory consolidation, movement control, addiction pathways, and sleep-wake regulation.
The technology is actively powering human clinical translations: experimental optogenetic gene therapies have demonstrated partial visual restoration in patients suffering from retinitis pigmentosa, while precision optic deep-brain mapping has identified refined targets for treating refractory Parkinson's tremors and severe clinical depression without the debilitating side effects of conventional neurosurgeries.
Who are the laureates and how will the award be conferred?
The 2026 laureates include Dr. Karl Deisseroth of Stanford University and the Howard Hughes Medical Institute, Prof. Peter Hegemann of Humboldt University of Berlin, and Prof. Georg Nagel of the University of Würzburg. The three scientists will equally divide the 11 million Swedish kronor award ($1.1 million), which will be presented alongside gold medals by King Carl XVI Gustaf at the traditional Nobel ceremony in Stockholm on December 10.
"Optogenetics has opened a luminous window into the most intricate machinery in the known universe—the human brain. It is an extraordinary testament to basic biology leading directly to profound medical enlightenment." — Prof. Thomas Perlmann, Secretary of the Nobel Committee
